4.7 Article

Novel P2X7 Antagonist Ameliorates the Early Phase of ALS Disease and Decreases Inflammation and Autophagy in SOD1-G93A Mouse Model

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Update of P2X receptor properties and their pharmacology: IUPHAR Review 30

Peter Illes et al.

Summary: P2X receptors are cationic channels consisting of seven different subunits, with researchers having determined their structure and function. In addition, primitive ligand-gated counterparts related to P2X receptors have been cloned, and various selective antagonists have been discovered.

BRITISH JOURNAL OF PHARMACOLOGY (2021)

Review Biochemistry & Molecular Biology

Where and Why Modeling Amyotrophic Lateral Sclerosis

Francesco Liguori et al.

Summary: Researchers have utilized a variety of in vivo models to dissect ALS, including both vertebrates and invertebrates. Concurrent and comparative analysis of these systems is essential to unravel the causes and mechanisms of ALS. These studies have helped to dissect the pathological pathways of ALS.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Neurosciences

P2X7 Receptor Antagonism as a Potential Therapy in Amyotrophic Lateral Sclerosis

Cristina Ruiz-Ruiz et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)

Editorial Material Pharmacology & Pharmacy

Duality of P2X7 Receptor in Amyotrophic Lateral Sclerosis

Cinzia Volonte et al.

FRONTIERS IN PHARMACOLOGY (2020)

Review Chemistry, Medicinal

Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs

Manoj Kumar Jaiswal

MEDICINAL RESEARCH REVIEWS (2019)

Review Clinical Neurology

Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies

David R. Beers et al.

LANCET NEUROLOGY (2019)

Review Clinical Neurology

Inflammation in ALS/FTD pathogenesis

Madelyn E. McCauley et al.

ACTA NEUROPATHOLOGICA (2019)

Review Biochemistry & Molecular Biology

Purinergic implication in amyotrophic lateral sclerosisfrom pathological mechanisms to therapeutic perspectives

M. Cieslak et al.

PURINERGIC SIGNALLING (2019)

Review Neurosciences

Astroglia-Derived ATP Modulates CNS Neuronal Circuits

Peter Illes et al.

TRENDS IN NEUROSCIENCES (2019)

Review Biochemistry & Molecular Biology

The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression

Geoffrey Burnstock et al.

PURINERGIC SIGNALLING (2018)

Review Pharmacology & Pharmacy

The therapeutic potential of purinergic signalling

Geoffrey Burnstock

BIOCHEMICAL PHARMACOLOGY (2018)

Review Physiology

Impaired Autophagy in Motor Neurons: A Final Common Mechanism of Injury and Death

Maria A. Gonzalez Porras et al.

PHYSIOLOGY (2018)

Review Clinical Neurology

Neuroinflammatory mechanisms in amyotrophic lateral sclerosis pathogenesis

Jason R. Thonhoff et al.

CURRENT OPINION IN NEUROLOGY (2018)

Review Biochemistry & Molecular Biology

Autophagy and Microglia: Novel Partners in Neurodegeneration and Aging

Ainhoa Plaza-Zabala et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Editorial Material Cell Biology

P2X7 receptor antagonism in amyotrophic lateral sclerosis

Ronald Sluyter et al.

NEURAL REGENERATION RESEARCH (2017)

Article Neurosciences

P2X7 Receptor Activation Modulates Autophagy in SOD1-G93A Mouse Microglia

Paola Fabbrizio et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2017)

Review Pharmacology & Pharmacy

Purinergic Signalling: Therapeutic Developments

Geoffrey Burnstock

FRONTIERS IN PHARMACOLOGY (2017)

Review Pharmacology & Pharmacy

P2X7 antagonists for CNS indications: recent patent disclosures

Paolo Pevarello et al.

PHARMACEUTICAL PATENT ANALYST (2017)

Article Biochemistry & Molecular Biology

MicroRNA-125b regulates microglia activation and motor neuron death in ALS

C. Parisi et al.

CELL DEATH AND DIFFERENTIATION (2016)

Review Multidisciplinary Sciences

Decoding ALS: from genes to mechanism

J. Paul Taylor et al.

NATURE (2016)

Review Neurosciences

Purinergic contribution to amyotrophic lateral sclerosis

Cinzia Volonte et al.

NEUROPHARMACOLOGY (2016)

Article Neurosciences

MicroRNAs: Newcomers into the ALS Picture

Cinzia Volonte et al.

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2015)

Article Pharmacology & Pharmacy

Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567

Anindya Bhattacharya et al.

BRITISH JOURNAL OF PHARMACOLOGY (2013)

Article Biochemistry & Molecular Biology

P2X7 receptor-induced death of motor neurons by a peroxynitrite/FAS-dependent pathway

Mandi Gandelman et al.

JOURNAL OF NEUROCHEMISTRY (2013)

Article Pharmacology & Pharmacy

Motor neuron dysfunction in a mouse model of ALS: Gender-dependent effect of P2X7 antagonism

Chiara Cervetto et al.

TOXICOLOGY (2013)

Article Neurosciences

P2X7 Receptors: Channels, Pores and More

C. Volonte et al.

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2012)

Review Neurosciences

Neuromodulation by Extracellular ATP and P2X Receptors in the CNS

Baljit S. Khakh et al.

NEURON (2012)

Editorial Material Clinical Neurology

Familial versus sporadic amyotrophic lateral sclerosis-a false dichotomy?

Kevin Talbot

BRAIN (2011)

Review Pharmacology & Pharmacy

ALS: Focus on purinergic signalling

Cinzia Volonte et al.

PHARMACOLOGY & THERAPEUTICS (2011)

Article Biochemistry & Molecular Biology

Methods in Mammalian Autophagy Research

Noboru Mizushima et al.

Article Clinical Neurology

Treatment with lithium carbonate does not improve disease progression in two different strains of SOD1 mutant mice

Chiara Pizzasegola et al.

AMYOTROPHIC LATERAL SCLEROSIS (2009)

Article Neurosciences

Extracellular ATP and Neurodegeneration

Cinzia Volonte et al.

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2003)